CA2095624A1 - Methode de ciblage de l'adn - Google Patents

Methode de ciblage de l'adn

Info

Publication number
CA2095624A1
CA2095624A1 CA2095624A CA2095624A CA2095624A1 CA 2095624 A1 CA2095624 A1 CA 2095624A1 CA 2095624 A CA2095624 A CA 2095624A CA 2095624 A CA2095624 A CA 2095624A CA 2095624 A1 CA2095624 A1 CA 2095624A1
Authority
CA
Canada
Prior art keywords
stranded dna
dna molecule
double
strand
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2095624A
Other languages
English (en)
Other versions
CA2095624C (fr
Inventor
Rafael D. Camerini-Otero
Margaret Mcintosh
Carol S. Camerini-Otero
Lance J. Ferrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2095624A1 publication Critical patent/CA2095624A1/fr
Application granted granted Critical
Publication of CA2095624C publication Critical patent/CA2095624C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6839—Triple helix formation or other higher order conformations in hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/153—Nucleic acids forming more than 2 strands, e.g. TFOs with the aid of a protein, e.g. recombinase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
CA002095624A 1990-11-09 1991-11-08 Methode de ciblage de l'adn Expired - Fee Related CA2095624C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61126890A 1990-11-09 1990-11-09
US611,268 1990-11-09
US73374491A 1991-07-24 1991-07-24
US733,744 1991-07-24
PCT/US1991/008200 WO1992008791A1 (fr) 1990-11-09 1991-11-08 Procede de ciblage d'adn

Publications (2)

Publication Number Publication Date
CA2095624A1 true CA2095624A1 (fr) 1992-05-10
CA2095624C CA2095624C (fr) 2000-06-13

Family

ID=27086477

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002095624A Expired - Fee Related CA2095624C (fr) 1990-11-09 1991-11-08 Methode de ciblage de l'adn

Country Status (8)

Country Link
US (1) US5460941A (fr)
EP (1) EP0556330B1 (fr)
JP (1) JP2739378B2 (fr)
AT (1) ATE217906T1 (fr)
AU (1) AU658386B2 (fr)
CA (1) CA2095624C (fr)
DE (1) DE69133018T2 (fr)
WO (1) WO1992008791A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4115693A (en) 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
US20020108136A1 (en) * 1997-03-21 2002-08-08 Sri Transgenic animals produced by homologous sequence targeting
US5861244A (en) * 1992-10-29 1999-01-19 Profile Diagnostic Sciences, Inc. Genetic sequence assay using DNA triple strand formation
US5731411A (en) * 1993-07-12 1998-03-24 The United States Of America As Represented By The Department Of Health And Human Services Promotion of homologous DNA pairing by RecA-derived peptides
AU7845194A (en) * 1993-09-28 1995-04-18 General Hospital Corporation, The Using antisense oligonucleotides to modulate nerve growth and to reverse beta/A4 amyloid-induced morphology
WO1995018236A1 (fr) * 1993-12-28 1995-07-06 Daikin Industries, Ltd. PROCEDE D'HYBRIDATION IN SITU AU MOYEN D'UNE PROTEINE RecA, ET PROTEINE RecA COMPRENANT UN MARQUEUR OU UN LIGAND UTILISEE POUR METTRE EN ×UVRE LEDIT PROCEDE
US5780296A (en) * 1995-01-17 1998-07-14 Thomas Jefferson University Compositions and methods to promote homologous recombination in eukaryotic cells and organisms
US5776744A (en) * 1995-06-07 1998-07-07 Yale University Methods and compositions for effecting homologous recombination
JPH11509423A (ja) * 1995-07-21 1999-08-24 ザ ガヴァメント オヴ ザ ユナイテッド ステイツ オヴ アメリカ、リプレゼンティッド バイ ザ セクレタリー、ディパートメント オヴ ヘルス アンド ヒューマン サーヴィスィーズ Ｒｅｃ支援ＤＮＡクローニング
KR19990067080A (ko) * 1995-10-27 1999-08-16 엘리엇 알. 램버그 특정 뉴클레오티드 서열의 검출방법 및 조성물
FR2757537B1 (fr) * 1996-12-23 1999-03-19 Genset Sa Procede destine a l'elimination de sequences specifiques lors de la production de banques d'adn
US5948653A (en) 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
JPH11151100A (ja) * 1997-11-19 1999-06-08 Aisin Cosmos Kenkyusho:Kk プローブによる核酸の検出方法
US6524856B1 (en) 1997-12-11 2003-02-25 Pangene Corporation Use of consensus sequences for targeted homologous gene isolation and recombination in gene families
NL1009369C2 (nl) * 1998-06-10 1999-12-13 Stichting Tech Wetenschapp Werkwijze voor het onderdrukken van de expressie van een gen.
JP4265028B2 (ja) * 1999-04-14 2009-05-20 アイシン精機株式会社 二本鎖ｄｎａの特異的切断方法およびそのためのキット
JP4465741B2 (ja) * 1999-07-02 2010-05-19 アイシン精機株式会社 二本鎖ｄｎａ断片の末端での連結
US6686180B2 (en) * 2000-04-04 2004-02-03 Baxter International Inc. Method for the production of bacterial toxins
US7045314B2 (en) * 2000-04-04 2006-05-16 Baxter International Inc. Method for the production of bacterial toxins
US20020132350A1 (en) * 2000-09-14 2002-09-19 Pioneer Hi-Bred International, Inc. Targeted genetic manipulation using Mu bacteriophage cleaved donor complex
JP4681129B2 (ja) * 2001-01-19 2011-05-11 株式会社アイシン・コスモス研究所 核酸末端領域の非対称的修飾法
AU2002303176A1 (en) 2001-03-27 2002-10-15 University Of Delaware Genomics applications for modified oligonucleotides
US7468244B2 (en) 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
WO2003089587A2 (fr) * 2002-04-16 2003-10-30 Promega Corporation Methode destinee a ameliorer une recombinaison homologue
JP4278412B2 (ja) 2003-03-13 2009-06-17 株式会社アイシン・コスモス研究所 部分的なｄｎａ鎖の相同的組換えによる遺伝子除去方法および遺伝子取得方法
US8293503B2 (en) * 2003-10-03 2012-10-23 Promega Corporation Vectors for directional cloning
EP1685247B1 (fr) * 2003-10-03 2009-11-11 Promega Corporation Vecteurs pour le clonage directionnel
ES2718482T3 (es) 2004-06-01 2019-07-02 Alere San Diego Inc Kit para amplificación de recombinasa polimerasa
US11845928B2 (en) * 2015-05-04 2023-12-19 Tsinghua University Methods and kits for fragmenting DNA
WO2018187779A1 (fr) 2017-04-07 2018-10-11 Sage Science, Inc. Systèmes et procédés de détection d'une variation structurale génétique à l'aide d'une purification d'adn électrophorétique intégrée

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888274A (en) * 1985-09-18 1989-12-19 Yale University RecA nucleoprotein filament and methods

Also Published As

Publication number Publication date
JP2739378B2 (ja) 1998-04-15
DE69133018T2 (de) 2003-01-02
WO1992008791A1 (fr) 1992-05-29
AU9111691A (en) 1992-06-11
EP0556330A4 (en) 1995-02-08
JPH06500926A (ja) 1994-01-27
US5460941A (en) 1995-10-24
AU658386B2 (en) 1995-04-13
EP0556330A1 (fr) 1993-08-25
ATE217906T1 (de) 2002-06-15
EP0556330B1 (fr) 2002-05-22
DE69133018D1 (de) 2002-06-27
CA2095624C (fr) 2000-06-13

Similar Documents

Publication Publication Date Title
CA2095624A1 (fr) Methode de ciblage de l'adn
CA2153898A1 (fr) Methode pour l'obtention de molecules d'adn a brin unique
CA2071536A1 (fr) Formation de la triple helice de l'adn dans les traitements a base d'oligonucleotides
EP1498494A3 (fr) Procédé de séquencage d'acides nucléiques
CA2125004A1 (fr) Amplification simultanee de cibles multiples
ATE225369T1 (de) Doppelsträngige peptidenukleinsäuren
AU3906895A (en) DNA amplification fingerprinting
AU6589094A (en) 7-deazapurine modified oligonucleotides
CA2320666A1 (fr) Nucleases 5' derivees d'adn polymerase thermostable
WO1994025588A3 (fr) OLIGONUCLEOTIDES ANTISENS DESTINES AU TRAITEMENT DES EFFETS IMMUNO-SUPPRESSEURS DU FACTEUR TRANSFORMANT DE CROISSANCE-β (TGF-β)
WO1994025477A3 (fr) Nouveaux acides nucleiques peptidiques
CA2236166A1 (fr) Expression de genes dans des vegetaux renforcee par des activateurs
AU5931290A (en) Nuclease resistant, single-stranded, non-naturally occurring nucleic acid molecules
WO1995006731A3 (fr) Acide nucleique enzymatique contenant un non-nucleotide
EP1762619A3 (fr) Genes de croissance aberrante presnets dans de multiples tumeurs
AU7572096A (en) Chimeric oligomers having an rna-cleavage activity
AU1884392A (en) Peptide nucleic acids
WO2004044140A3 (fr) Composes oligomeres 2'-substitues et compositions destinees a etre utilisees dans des modulations genetiques
WO1999057325A3 (fr) Melanges d'enzymes
WO1998026093A3 (fr) Formation en epingle a cheveux d'analogue de nucleotides fluorescents pour la detection de l'hybridation d'acides nucleiques
EP0579771A4 (en) Single-stranded circular oligonucleotides
EP0348529A4 (en) Method for detecting target nucleic acid in specimen
WO1995006764A3 (fr) Oligonucleotides ayant une activite de segmentation de l'arn
WO1995003406A3 (fr) Augmentation de l'inhibition oligonucleotidique de la production proteique, de la proliferation cellulaire et/ou de la multiplication d'agents pathogenes de maladie infectieuse
CA2185189A1 (fr) Methode de preparation de poly(diorganosiloxanes) avec des diorganyloxyorganylsilyles ou triorganyloxysilyles comme groupes terminaux; melanges reticulables renfermant ces composes et leur utilisation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed